This trial is testing two different combinations of drugs to see which is more effective and has fewer side effects in treating locally advanced pancreatic cancer.
1 Primary · 1 Secondary · Reporting Duration: Time from first dose until subject has reached 90 days post last active study treatment
20 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase 1
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: